Presenting the road project, Roads Authority’s Social Planning Officer Boston Kadzamila, said currently, the road is narrow ...

Blantyre - Aids-ravaged Malawi, where over a tenth of the population is HIV positive, records on average 1 000 new cases weekly, a top government official said on Saturday. "It’s a great concern to us ...

tests for HIV and other diseases, flu shots, and blood pressure and glucose monitoring. Between greetings, Devine, executive director of the nonprofit group Hearts for the Homeless, commiserated ...

tests for HIV and other diseases, flu shots, and blood pressure and glucose monitoring. Between greetings, Devine, executive director of the nonprofit group Hearts for the Homeless, commiserated ...

Get Instant Summarized Text (Gist) Analysis of large health databases indicates that patients taking nucleoside reverse transcriptase inhibitors (NRTIs), drugs used for HIV and hepatitis B, have a ...

We're watching the largest HIV treatment programme in the world unravel in real time. We don't need perfection, but we need a combination of urgency, action, and strategy to save it, argues Professor ...

Laboratory monitoring for HIV disease in resource-limited settings has now become one of the key challenges for access and success, to prevent ART failure and to switch to second- and third-line ...

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are ...

The Los Angeles LGBT Center says lives are now at risk since funding for HIV prevention has been cut off by the county. In a sharply worded post on Instagram, Joe Hollendoner, the nonprofit’s ...

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that people living with HIV need to take lifelong antiretroviral treatment.

For HIV, researchers are designing antigens that trigger the production of antibodies that can target the MPER region with both protein and lipid specificity, just like bNAbs do.